BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16504865)

  • 1. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
    Jen YM; Lin YC; Wang YB; Wu DM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):322-7. PubMed ID: 16504865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.
    Saarilahti K; Kouri M; Collan J; Hämäläinen T; Atula T; Joensuu H; Tenhunen M
    Radiother Oncol; 2005 Mar; 74(3):251-8. PubMed ID: 15763305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
    Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
    J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
    Ortholan C; Chamorey E; Benezery K; Thariat J; Dassonville O; Poissonnet G; Bozec A; Follana P; Peyrade F; Sudaka A; Gerard JP; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):178-86. PubMed ID: 18565687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
    Baharudin A; Khairuddin A; Nizam A; Samsuddin AR
    J Laryngol Otol; 2009 Jan; 123(1):108-13. PubMed ID: 18452635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sparing of contralateral major salivary glands has a significant effect on oral health in patients treated with radical radiotherapy of head and neck tumors.
    Beer KT; Zehnder D; Lussi A; Greiner RH
    Strahlenther Onkol; 2002 Dec; 178(12):722-6. PubMed ID: 12491061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma.
    Pow EH; McMillan AS; Leung WK; Wong MC; Kwong DL
    Clin Oral Investig; 2003 Dec; 7(4):230-4. PubMed ID: 12955605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.
    Braam PM; Roesink JM; Raaijmakers CP; Busschers WB; Terhaard CH
    Radiat Oncol; 2007 Jan; 2():3. PubMed ID: 17207274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS; Weber RS; Garden AS
    J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small salivary gland size in patients with xerostomia of unknown etiology.
    Ono K; Tanaka T; Inoue H; Ansai T; Sato-Wakasugi N; Muraoka K; Yokota M; Takehara N; Morimoto Y; Inenaga K
    Arch Oral Biol; 2009 Apr; 54(4):369-73. PubMed ID: 19185851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.
    Kwong DL; Pow EH; Sham JS; McMillan AS; Leung LH; Leung WK; Chua DT; Cheng AC; Wu PM; Au GK
    Cancer; 2004 Oct; 101(7):1584-93. PubMed ID: 15378492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours.
    Cankar K; Finderle Z; Jan J
    Caries Res; 2011; 45(2):136-41. PubMed ID: 21447949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.